Significance of platelet activation in sickle cell anaemia
- PMID: 16805172
- DOI: 10.4314/njm.v15i2.37100
Significance of platelet activation in sickle cell anaemia
Abstract
Background: There is increasing evidence suggesting the contribution of platelets in the vaso-occlusive phenomena found in sickle cell anaemia. This study is aimed at using simple, inexpensive parameters to determine the role of platelets in the steady state and vaso-occlusive crisis state of Nigerian sickle cell anaemia patients.
Methods: The circulating platelet aggregate (CPA) ratio, platelet factor-3 availability (PF-3) and platelet counts of 60 adult Nigerian sickle cell anaemia patients were studied.
Results: The CPA ratio in the sickle cell anaemia (SCA) patients in steady state (SS) was 0.93 +/- 0.05, 0.89 +/- 0.04 during vaso-occlusive crisis (VOC) and 0.98 +/- 0.02 in the control group (C). The values in the vaso-occlusive crisis and in steady state were significantly lower than in the control group (P < 0.05). PF3 availability in steady state and vaso-occlusive crisis were 29.7 +/- 4.0 secs and 28.4 +/- secs respectively. The times are significantly shorter when compared with the control group with a time of 36.2 +/- 4.3 secs (P < 0.05). There was however no significant difference between the two sickle cell groups. Platelet count was significantly raised in the steady state patients 224.3 +/- 46.3 x 10(9)/L when compared with controls of 196.6 +/- 39.3 x 10(9)/L (P < 0.05). There was a significant fall during VOC to 140.6 +/- 36.3 x 10(9)/L (P < 0.05). The difference between the two sickle cell groups is significant (P < 0.05).
Conclusion: This study indicates varying degrees of partial activation of platelets in vivo in the steady state and vaso-occlusive crisis state of sickle cell anaemia. It support's a contribution of platelet to the vascular occlusion that underlies much of the morbidity in the disease.
Similar articles
-
Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis.Acta Haematol. 1993;89(4):180-3. doi: 10.1159/000204519. Acta Haematol. 1993. PMID: 8212998
-
Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India.Ann Hematol. 2019 Oct;98(10):2257-2265. doi: 10.1007/s00277-019-03776-x. Epub 2019 Aug 22. Ann Hematol. 2019. PMID: 31440871 Clinical Trial.
-
Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion.Stroke. 1979 Jul-Aug;10(4):464-6. doi: 10.1161/01.str.10.4.464. Stroke. 1979. PMID: 505486
-
The Neuropeptide Substance P is Elevated in Sickle Cell Disease and is a Marker of Severity of Vaso-occlusive Crisis.Niger Med J. 2024 Sep 26;65(4):398-402. doi: 10.60787/nmj-v65i3-419. eCollection 2024 Jul-Aug. Niger Med J. 2024. PMID: 39398396 Free PMC article. Review.
-
Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review.Cureus. 2022 Aug 24;14(8):e28337. doi: 10.7759/cureus.28337. eCollection 2022 Aug. Cureus. 2022. PMID: 36176876 Free PMC article. Review.
Cited by
-
Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease.Circulation. 2007 Mar 27;115(12):1551-62. doi: 10.1161/CIRCULATIONAHA.106.658641. Epub 2007 Mar 12. Circulation. 2007. PMID: 17353439 Free PMC article.
-
The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease.Mediterr J Hematol Infect Dis. 2011;3(1):e2011028. doi: 10.4084/MJHID.2011.028. Epub 2011 Jul 8. Mediterr J Hematol Infect Dis. 2011. PMID: 21869914 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical